Advanced search
Publication Cover
Baylor University Medical Center Proceedings
The peer-reviewed journal of Baylor Scott & White Health
Volume 32, 2019 - Issue 1
Submit an article Journal homepage
42
Views
0
CrossRef citations to date
0
Altmetric
Case Studies

An intriguing case of anemia and renal failure

Krishna M. BaradhiDivision of Nephrology, University of Oklahoma–Tulsa, Tulsa, OklahomaCorrespondence[email protected]
ORCID Iconhttp://orcid.org/0000-0003-2776-4935
, MD ORCID Icon
Pages 78-79 | Received 18 Aug 2018, Accepted 22 Oct 2018, Published online: 24 Jan 2019

  • Yung RL, Richardson BC. Drug-induced lupus. Rheum Dis Clin North Am. 1994;20(1):61–86.
  • Cameron HA, Ramsay LE. The lupus syndrome induced by hydralazine: a common complication with low dose treatment. Br Med J (Clin Res Ed). 1984;289(6442):410–412. doi: 10.1136/bmj.289.6442.410.
  • Agarwal G, Sultan G, Werner SL, Hura C. Hydralazine induces myeloperoxidase and proteinase 3 anti-neutrophil cytoplasmic antibody vasculitis and leads to pulmonary renal syndrome. Case Rep Nephrol. 2014;2014:1. doi: 10.1155/2014/868590.
  • Cambridge G, Wallace H, Bernstein RM, Leaker B. Autoantibodies to myeloperoxidase in idiopathic and drug-induced systemic lupus erythematosus and vasculitis. Br J Rheumatol. 1994;33(2):109–114. doi: 10.1093/rheumatology/33.2.109.
  • Bernstein RM. Rheumatic complications of drugs and toxins. In: Maddison PJ, Isenberg DA, Woo P, Glass DN, eds. Oxford Textbook of Rheumatology. 2nd ed. New York, NY: Oxford University Press; 1998:1689–1700.
  • Chisholm JC Jr. Acute low-dose hydralazine induced lupus syndrome (HILS). J Natl Med Assoc. 1981;73(3):278–280.
  • Kumar B, Strouse J, Swee M, Lenert P, Suneja M. Hydralazine-associated vasculitis: overlapping features of drug-induced lupus and vasculitis. Semin Arthritis Rheum. 2018. pii: S0049-0172(17)30433-X. doi: 10.1016/j.semarthrit.2018.01.005.
  • Finks SW, Finks AL, Self TH. Hydralazine-induced lupus: maintaining vigilance with increased use in patients with heart failure. South Med J. 2006;99(1):18–22. doi: 10.1097/01.smj.0000197121.12352.19.
  • Timlin H, Liebowitz JE, Jaggi K, Geetha D. Outcomes of hydralazine induced renal vasculitis. Eur J Rheumatol. 2018;5(1):5–8. doi: 10.5152/eurjrheum.2017.17075.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.